The imidazolyl quinoline derivative of flavonoids, XHN27, a potent aromatase inhibitor, significantly suppresses the proliferation of breast cancer T47D cells, determined after screening a library of 7000 compounds [267]. Here, CYP19A1 is linked to breast carcinoma.